If successful, this would allow us to test whether reducing the calcification load could lead to an improvement of behavioral symptoms, which could open up studies on the therapeutic potential of modulating TREM2 in PFBC patients. This evidence concerns the gene TREM2 and bilateral striopallidodentate calcinosis.